NCT06548555 A Study to Evaluate the Impact of Long-term Digital Education vs Standard of Care on LDL-C Levels in Post Myocardial Infarction Patients Status COMPLETED Phase N/A
NCT06546670 A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease Status RECRUITING Phase PHASE1/PHASE2
NCT06531499 A Study of Radiation Dosimetry, Safety, and Tolerability of Extended Lutetium (177Lu) Vipivotide Tetraxetan Treatment in Chemo-naïve Adults With Metastatic Castration-resistant Prostate Cancer: RADIOpharmaceutical DOSimetry Evaluation (RADIODOSE) Study Status RECRUITING Phase PHASE1
NCT06517758 A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 85 Years With gMG. Status RECRUITING Phase PHASE3
NCT06517732 Study to Collect in a Real-world populatIon Data on the Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe Hidradenitis Suppurativa (HS) in Routine Clinical Practice in the Russian Federation Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06517719 Real-world Experience With Lutetium Vipivotide Tetraxetan in Metastatic Castration Resistant Prostate Cancer Status RECRUITING Phase N/A
NCT06514534 Open-label Study of Asciminib for CML-CP or CML-AP Patients With T315I Mutation Who Are Resistant, Intolerant or Ineligible to Ponatinib. Status RECRUITING Phase PHASE2
NCT06486779 Kesimpta (Ofatumumab) in Greek Multiple Sclerosis Patients - an Observational Study Status RECRUITING Phase N/A
NCT06470048 A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis Status RECRUITING Phase PHASE2
NCT06462469 Study of Efficacy and Safety of Ruxolitinib in Patients With Grade II to IV Steroid-refractory Acute Graft vs. Host Disease Status RECRUITING Phase PHASE4
NCT06460324 A Study to Assess COVID-19 Vaccination Immune Response in Multiple Sclerosis Patients Treated With Ofatumumab Status COMPLETED Phase N/A
NCT06444113 Concentration of Ofatumumab in the Breast Milk of Lactating Women With Relapsing Forms of Multiple Sclerosis Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT06444087 Patient's Perspective on the Evolution of Hidradenitis Suppurativa Burden After Secukinumab Initiation Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06439082 A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE) Status RECRUITING Phase PHASE3
NCT06431763 A Study to Investigate LDL-cholesterol Lowering With Inclisiran Compared to Bempedoic Acid in Patients With Atherosclerotic Cardiovascular Disease. Status COMPLETED Phase PHASE4
NCT06431750 Prospective Observational Study to Evaluate Secukinumab Treatment Effectiveness in Pediatric Patients With Active Juvenile Enthesitis-related or Psoriatic Arthritis Status NOT_YET_RECRUITING Phase N/A
NCT06427811 Clinical Study of Asciminib in Previously Treated Indian Patients With Ph+ CML-CP Without T315I Mutation and in Patients With Ph+ CML-CP With T315I Mutation Status COMPLETED Phase PHASE4
NCT06411639 Pharmacokinetics Study of Ianalumab in Chinese Participants With Autoimmune Diseases Status WITHDRAWN Phase PHASE1